Advanced Medical Solutions Group (LSE:AMS) FCF Margin %: 7.59% (As of Dec. 2025) — 48% Below Median


LSE:AMS Advanced Medical Solutions Group PLC LSE:AMS
89 GF Score
Price £2.79
GF Value £3.69
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Advanced Medical Solutions Group FCF Margin %?

Advanced Medical Solutions Group LSE:AMS +16.04% 89 FCF Margin % is 7.59% as of Dec. 2025, which is 48% below its 10-year median of 14.54. GuruFocus rates LSE:AMS with a GF Score™ of 89/100 and a GF Value™ of £3.69 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Advanced Medical Solutions Group ranks better than 70.31% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Advanced Medical Solutions Group's Free Cash Flow for the six months ended in Dec. 2025 was £9.0 Mil. Advanced Medical Solutions Group's Revenue for the six months ended in Dec. 2025 was £118.2 Mil. Therefore, Advanced Medical Solutions Group's FCF Margin % for the quarter that ended in Dec. 2025 was 7.59%.

As of today, Advanced Medical Solutions Group's current FCF Yield % is 3.30%.

The historical rank and industry rank for Advanced Medical Solutions Group's FCF Margin % or its related term are showing as below:

LSE:AMS' s FCF Margin % Range Over the Past 10 Years
Min: 1.98   Med: 14.54   Max: 22.62
Current: 8.73


During the past 13 years, the highest FCF Margin % of Advanced Medical Solutions Group was 22.62%. The lowest was 1.98%. And the median was 14.54%.

LSE:AMS's FCF Margin % is ranked better than
70.31% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: -0.1 vs LSE:AMS: 8.73


Advanced Medical Solutions Group FCF Margin % Related Terms


Advanced Medical Solutions Group FCF Margin % Historical Data

* Premium members only.

The historical data trend for Advanced Medical Solutions Group's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Medical Solutions Group FCF Margin % Chart

Advanced Medical Solutions Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.62 13.60 1.98 6.05 8.73

Advanced Medical Solutions Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.01 4.59 6.96 9.94 7.59

LSE:AMS vs ISRG, BDX, MDLN: FCF Margin % Comparison

For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Medical Solutions Group FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Advanced Medical Solutions Group's FCF Margin % falls into.


LSE:AMS
89GF Score
Advanced Medical Solutions Group PLC LSE:AMS
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Advanced Medical Solutions Group FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Advanced Medical Solutions Group's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=19.987/228.936
=8.73 %

Advanced Medical Solutions Group's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=8.974/118.167
=7.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 7.59% mean?
Advanced Medical Solutions Group (LSE:AMS) has a FCF Margin % of 7.59% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Advanced Medical Solutions Group and its competitors. This is 48% below median its historical median of 14.54. Over the past decade, Advanced Medical Solutions Group's FCF Margin % has ranged from 1.98 to 22.62. According to the industry distribution chart, Advanced Medical Solutions Group ranks #242 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 29.7%.
Is Advanced Medical Solutions Group's FCF Margin % too high?
Advanced Medical Solutions Group's current FCF Margin % of 7.59% is 48% below median its 10-year median of 14.54. Over the past 10 years, this metric has ranged from a low of 1.98 to a high of 22.62. Based on the distribution chart, Advanced Medical Solutions Group ranks #242 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Advanced Medical Solutions Group has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Solutions Group's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Advanced Medical Solutions Group ranks #242 out of 815 companies for FCF Margin %. This puts Advanced Medical Solutions Group in the upper half of its industry. Historically, Advanced Medical Solutions Group's own FCF Margin % has ranged from 1.98 to 22.62 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Advanced Medical Solutions Group and its competitors. Advanced Medical Solutions Group's current FCF Margin % is 7.59%, which is 48% below median its own 10-year median of 14.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Solutions Group stock overvalued right now?
Based on GuruFocus' analysis, Advanced Medical Solutions Group (LSE:AMS) is currently considered Modestly Undervalued. The stock's GF Value™ is £3.69, compared to a current price of £2.79 — trading 24.5% below its estimated fair value. The current FCF Margin % is 7.59%, which is 48% below median its 10-year median of 14.54. Advanced Medical Solutions Group's overall GF Score™ is 89/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Advanced Medical Solutions Group (LSE:AMS), the current FCF Margin % is 7.59% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Advanced Medical Solutions Group (LSE:AMS) Overvalued in 2026?

Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued. The current stock price of £2.79 is trading 24.5% below its estimated GF Value™ of £3.69. GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.

Key valuation signals for LSE:AMS:

  • FCF Margin %: 7.59% (48% below median its 10-year median of 14.54)
  • GF Value™: £3.69 vs. price of £2.79 (24.5% below fair value)
  • GF Score™: 89/100 with 6 warning signs

No single metric tells the full story. See the LSE:AMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Advanced Medical Solutions Group Business Description

Other Exchanges AMSl:UKAQA:Germany
Address Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
89GF Score

Get the complete analysis for LSE:AMS

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£2.79
Price
£3.69
GF Value